Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?

BACKGROUND/AIMS: Screening for latent tuberculosis infection is mandatory before starting anti-tumor necrosis factor therapy. New assays based on interferon-γ (IFN-γ) release have recently become available and may be more accurate. The aim of this study was to compare QuantiFERON-TB and tuberculin s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Turk J Gastroenterol
Päätekijät: Cabriada, José Luis, Ruiz-Zorrilla, Rafael, Barrio, Jesús, Atienza, Ramón, Huerta, Alain, Rodríguez-Lago, Iago, Bernal, Antonio, Herrero, César
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Turkish Society of Gastroenterology 2018
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6284653/
https://ncbi.nlm.nih.gov/pubmed/29755013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2018.17162
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia